The Washington Biotechnology and Biomedical Association will host a panel discussion titled “Genomic Approaches to Understanding Disease and Enhancing Drug Development at the Institute for Systems Biology. Speakers include Eric Schadt, executive scientific director of Rosetta Inpharmatics, Jerry Radich, a genetics researcher at the Fred Hutchinson Cancer Research Center and Leroy Hood, president of the Institute for Systems Biology. Cost is $50 for WBBA members, and $100 for non-members. Register online at http://www.washbio.org/cde.cfm?event=222157.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
